$466.00
-1.06-0.23%
Last update: Nov 13, 12:08 PM
Amgen Inc (AMGN) Stock Price, Quote, News & History
AMGNNASDAQ
Amgen reported positive Phase 3 OASIZ-301 trial data for dazodalibep, showing significant reductions in systemic Sjögren's disease activity.
You can purchase shares of Amgen (NASDAQ:AMGN) through any online brokerage.
Other companies in Amgen’s space includes: AbbVie Inc (NYSE:ABBV), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Moderna Inc (NASDAQ:MRNA).
Amgen has a consensus price target of $432.67.
The stock price for Amgen (NASDAQ: AMGN) is $465.995 last updated November 13, 2026 at 12:08 PM EST.
There are no upcoming dividends for Amgen.
Amgen does not have any upcoming earnings scheduled.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first...
